Como o vírus da covid-19 se replica? (Replicação viral do SARS- CoV-2) [Atualizado]

Patologia fácil
3 Sept 202105:49

Summary

TLDRThe video explains the complex process of how the SARS-CoV-2 virus infects human cells. It details the interaction between the virus's spike protein and the ACE2 receptor, followed by the critical role of the host cell's TMPRESS2 protein. The virus enters the cell and uses the host's machinery to replicate its RNA, producing viral proteins. The virus then assembles within the cell, exiting via exocytosis, and infects new cells. The video also highlights the misconception about chloroquine's effectiveness in preventing infection, emphasizing the importance of understanding viral replication mechanisms for potential treatments.

Takeaways

  • 😀 The Spike protein of SARS-CoV-2 binds to the ACE2 receptor on host cells, initiating infection.
  • 😀 The interaction between the Spike protein and ACE2 is not enough for infection; the host cell's TMPRESS2 protein is also required.
  • 😀 TMPRESS2 helps expose hydrophobic regions in the Spike protein, allowing the virus to enter the cell membrane.
  • 😀 Once inside the cell, the viral RNA is translated into proteins, and viral replication begins early in the infection process.
  • 😀 The virus remodels the host cell's gene expression to prevent immune detection and further facilitate viral replication.
  • 😀 The virus is assembled in the rough endoplasmic reticulum and Golgi apparatus, and then packaged into vesicles.
  • 😀 A host protein called furin cleaves the Spike protein, enhancing the virus's infectivity. Variants like Delta have more efficient cleavage sequences.
  • 😀 The virus exits the host cell via exocytosis or sometimes through lysosomes, though the exact reasons for lysosomal exit are still unclear.
  • 😀 Understanding the SARS-CoV-2 replication cycle is crucial for developing antiviral treatments and infection inhibitors.
  • 😀 Early studies incorrectly suggested that chloroquine inhibited viral infection due to experiments on Vero cell lines, which lack TMPRESS2.
  • 😀 In human cells, chloroquine is ineffective in blocking SARS-CoV-2 infection because the virus primarily enters through TMPRESS2, not by endocytosis.

Q & A

  • What is the role of the Spike protein in the infection process of SARS-CoV-2?

    -The Spike protein plays a critical role in recognizing and binding to the ACE2 receptor on the host cell. This binding alone is not enough for the virus to infect the cell, as it also requires the assistance of another host protein to facilitate the process.

  • How does the host protein, known as TMPRSS2, contribute to the viral infection process?

    -TMPRSS2 is responsible for cleaving a region of the Spike protein, called subunit 1, exposing hydrophobic regions that allow the Spike protein to fuse with the cell's plasma membrane, enabling the virus to enter the host cell.

  • What happens after the virus enters the host cell?

    -Once inside the host cell, the viral RNA is translated by cellular ribosomes, producing viral proteins. These proteins are essential for the replication of the virus and the subsequent production of new viral particles.

  • How does the virus avoid being detected and eliminated by the host cell?

    -The virus remodels the host cell's gene expression to suppress immune responses, particularly inhibiting the expression of interferon genes. This suppression is associated with more severe cases of COVID-19.

  • What is the role of ribosomes in viral replication?

    -Ribosomes within the host cell translate the viral RNA into proteins, including those necessary for viral replication. This allows the virus to produce copies of its genetic material and proteins to assemble new viral particles.

  • How are viral proteins processed inside the host cell?

    -Viral proteins are processed within the host cell's endoplasmic reticulum, where they undergo necessary modifications. The viral assembly then continues in the Golgi complex, where the virus is fully assembled before being released from the cell.

  • What happens after the viral particles are fully assembled?

    -Once the viral particles are fully assembled in the Golgi complex, they are packaged into vesicles and released from the cell through exocytosis. This process enables the virus to infect new cells.

  • What role does the protein Furin play in viral infectivity?

    -Furin is a host protein that activates the Spike protein by making a cleavage cut, enhancing the virus's ability to infect host cells. Variants like Delta have more efficient Furin recognition sites, making them more infectious.

  • Why is chloroquine ineffective in inhibiting SARS-CoV-2 infection in humans?

    -Chloroquine was initially thought to inhibit the virus in certain cell lines, like the Vero cell line, by altering the conditions within endosomes. However, in human cells, where the virus primarily enters via the ACE2 receptor (not endocytosis), chloroquine has little effect.

  • What does the comparison between chloroquine use and leaving a door open suggest about its ineffectiveness?

    -The comparison suggests that using chloroquine to block viral entry is like leaving one door open for the virus to enter while blocking another. Since most human infections rely on ACE2 receptors, blocking endocytosis (through chloroquine) does not prevent the majority of viral infections.

Outlines

plate

This section is available to paid users only. Please upgrade to access this part.

Upgrade Now

Mindmap

plate

This section is available to paid users only. Please upgrade to access this part.

Upgrade Now

Keywords

plate

This section is available to paid users only. Please upgrade to access this part.

Upgrade Now

Highlights

plate

This section is available to paid users only. Please upgrade to access this part.

Upgrade Now

Transcripts

plate

This section is available to paid users only. Please upgrade to access this part.

Upgrade Now
Rate This

5.0 / 5 (0 votes)

Related Tags
SARS-CoV-2viral infectionSpike proteincell biologyTMPRSS2chloroquineCOVID-19viral entryimmune responseviral replicationtreatment strategies